Facebook
X
LinkedIn
ForwardSolid Tumor, NeuroOnc, Late Effects 6/11/2026
This content reviews neuroblastoma including its presentation, diagnostic evaluation, prognostic factors, and staging‑based treatment strategies. The class also provides an overview of common pediatric solid tumors, their key characteristics, therapies, and associated complications. It also highlights cancer‑survivor demographics and emphasizes recognition of late effects from treatment to support long‑term follow‑up and survivorship care.
Target Audience
Nurses
Learning Objectives
- Identify the most common pediatric solid tumor malignancies.
- Describe neuroblastoma and the factors affecting prognosis.
- Recognize late effects associated with cancer treatment.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Children’s National Hospital. Children’s National Hospital is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Children’s National Hospital Accreditation Provider# 4008362.
Available Credit
- 7.00 ANCCChildren’s National Hospital will provide 7.00 Nursing Contact Hours for this Live activity.
- 7.00 ParticipationSuccessful completion of this continuing education activity.
Please click the red “Take Course” button to begin.
This will guide you through the steps needed to receive your CE certificate. You will only be able to complete these steps after you have attended the education session and submitted your attendance code.